Research Interests

G-protein–coupled receptors (GPCRs) remain the source for most therapeutic drug targets. The recent breakthroughs in GPCR structural biology has established the basis for virtual screening as well as detailed information for structure-based drug design (SBDD) targeting this family of receptors. We are interested in integrating the structure information and the emerging new dimersions of GPCR pharmacology with medicinal chemistry approaches, towards the design and discovery of novel drug candidates.